High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B
Hamid Wani(Hamad Medical Corporation), Muneera Almohannadi(Hamad Medical Corporation), Anil John(Pushpagiri Medical College), Moutaz Derbala(Weill Cornell Medical College in Qatar), Saad Al Kaabi(Hamad General Hospital), Manik Sharma(Hamad General Hospital), Rajvir Singh(Hamad Medical Corporation)
Cited by 5
Related Papers
Artificial intelligence in medical education - perception among medical students
|BMC Medical Education|2024|121
Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study
|Journal of Gastroenterology and Hepatology|2005|73
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole
|Annals of Tropical Medicine and Parasitology|2002|40
Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations
|Annals of Tropical Medicine and Parasitology|2000|39